Extended Data Fig. 10: Acetylation of c-Myc in Lys148 after inhibition of HDAC6 in sensitive and resistant BC cancer cells. | Nature Cancer

Extended Data Fig. 10: Acetylation of c-Myc in Lys148 after inhibition of HDAC6 in sensitive and resistant BC cancer cells.

From: Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

Extended Data Fig. 10: Acetylation of c-Myc in Lys148 after inhibition of HDAC6 in sensitive and resistant BC cancer cells.The alternative text for this image may have been generated using AI.

The western blot shows the accumulation of ac-K148-c-Myc after HDAC6 is inhibited by ricolinostat in MDA-MB-453 (sensitive) and MDA-MB-436 (resistant) lines. WT-blot results were reproduced n = 3 times from independent experiments.

Source data

Back to article page